RxDoctor Payments Data

Ajaipal Kang

Plastic and Reconstructive Surgery · Erie, PANPI 1306846035

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 43 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 23.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $303 and has fallen 74.7% since, to $77 in 2025. That places this record below the midpoint for plastic and reconstructive surgery clinicians in PA, where the typical reported total is $1,487.

$1,388in general payments, 2019–2025

Across 43 payments — averaging $32.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Musculoskeletal Transplant Foundation Inc.$326
  • Merz North America, Inc.$165
  • Johnson & Johnson$144
  • Sientra, Inc.$115
  • Mentor Worldwide LLC$108
  • Polynovo North America LLC$73
  • plus $458 from 16 others

What the payments were for

  • Food & beverage$1,388100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,388 in reported general payments places this provider in the 45th percentile of 108 plastic and reconstructive surgery providers in Pennsylvania.

See all plastic and reconstructive surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$246,846
Medicare patients
487
Services billed
949

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluorouracil76$5,533
Doxycycline Hyclate11$107

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Erie

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →